{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:18:58Z","timestamp":1789395538140,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bulcan.2021.01.010","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T03:28:15Z","timestamp":1617334095000},"page":"449-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Platinum-induced nausea and vomiting in patients treated for head and neck cancer"],"prefix":"10.1016","volume":"108","author":[{"given":"Audrey","family":"Rambeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cherifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00e9","family":"Neviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idlir","family":"Licaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Clarisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2021.01.010_bib0120","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.010_bib0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bulcan.2019.02.002","article-title":"Antineoplastic drug induced nausea and vomiting: what is the clinical practice in 2018? An update of AFSOS clinical guidelines","volume":"106","author":"Jovenin","year":"2019","journal-title":"Bull Cancer [Internet]"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.010_bib0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2021.01.010_bib0135","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"New Eng J Med"},{"issue":"17","key":"10.1016\/j.bulcan.2021.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med [Internet]"},{"issue":"15 Suppl.","key":"10.1016\/j.bulcan.2021.01.010_bib0145","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1200\/JCO.2019.37.15_suppl.6002","article-title":"TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent\/metastatic head and neck squamous cell carcinoma (R\/M HNSCC)","volume":"37","author":"Guigay","year":"2019","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.bulcan.2021.01.010_bib0150","article-title":"Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity\u00a0\u2013\u00a0State of the art","volume":"19","author":"Grunberg","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2021.01.010_bib0155","series-title":"Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients","author":"Kaushal","year":"2020"},{"key":"10.1016\/j.bulcan.2021.01.010_bib0160","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0347(200008)22:5<474::AID-HED6>3.0.CO;2-I","article-title":"Pre-treatment swallowing function in patients with head and neck cancer","author":"Pauloski","year":"2000","journal-title":"Head Neck [Internet]"},{"issue":"12","key":"10.1016\/j.bulcan.2021.01.010_bib0165","first-page":"3531","article-title":"Head and neck cancer patients\u2019 perceptions of swallowing following chemo radiotherapy","volume":"23","author":"Patterson","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2021.01.010_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2012.04.022","article-title":"Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy","volume":"430","author":"Stegemann","year":"2012","journal-title":"Int J Pharma"},{"issue":"7","key":"10.1016\/j.bulcan.2021.01.010_bib0175","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1503\/cmaj.050176","article-title":"\u201cAvoid the crush\u201d: Hazards of medication administration in patients with dysphagia or a feeding lube","volume":"172","author":"Cornish","year":"2005","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.010_bib0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jpainsymman.2006.10.018","article-title":"Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool","volume":"34","author":"Molassiotis","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2021.01.010_bib0185","first-page":"9","article-title":"Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients","author":"Kaushal","year":"2015","journal-title":"E Cancer Med Sc"},{"issue":"3","key":"10.1016\/j.bulcan.2021.01.010_bib0190","first-page":"1131","article-title":"How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study","volume":"24","author":"Vanbockstael","year":"2016","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.010_bib0195","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","article-title":"Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study group of Japan","volume":"20","author":"Tamura","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2021.01.010_bib0200","article-title":"Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study","volume":"47","author":"Molassiotis","year":"2014","journal-title":"J Pain Symptom Manage [Internet]"},{"issue":"6","key":"10.1016\/j.bulcan.2021.01.010_bib0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/cas.12146","article-title":"Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis","volume":"104","author":"Sekine","year":"2013","journal-title":"Cancer Sci [Internet]"},{"issue":"1","key":"10.1016\/j.bulcan.2021.01.010_bib0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.1997.15.1.116","article-title":"Determinants of postchemotherapy nausea and vomiting in patients with cancer","volume":"15","author":"Osoba","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.010_bib0215","first-page":"179","article-title":"The impact of chemotherapy-induced nausea and vomiting on health-related quality of life","volume":"15","author":"Ballatori","year":"2007","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.bulcan.2021.01.010_bib0220","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1177\/1078155219828806","article-title":"Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults","volume":"25","author":"Patel","year":"2019","journal-title":"J Oncol Pharm Pract [Internet]"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.010_bib0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bfopcu.2018.04.002","article-title":"Formulation optimization and evaluation of fast dissolving film of aprepitant by using design of experiment","volume":"56","author":"Bala","year":"2018","journal-title":"Bull Fac Pharmacy, Cairo Univ"},{"issue":"2","key":"10.1016\/j.bulcan.2021.01.010_bib0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1470-2045(19)30678-3","article-title":"Olanzapine 5mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Hashimoto","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121001077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:41Z","timestamp":1757792021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0007455121001077"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platinum-induced nausea and vomiting in patients treated for head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}